Winner of the CEO of the Year Awards.
Tesla Diagnostix
Tesla Diagnostix is one of the 2023 winners of the SME CEO of the Year Awards.
![Award Logo](/wp-content/themes/wp-bootstrap-starter/aigm-image-handler/handler.webp?src=https%3A%2F%2Fsmenews.digital%2Fwp-content%2Fuploads%2F2023%2F10%2FCEO-of-the-Year-Awards-Web-Logos-Dark-01.png&width=654&height=auto&v=1)
![Winner Image](https://smenews.digital/wp-content/uploads/customer_uploads/1709214788-575ca2727e8bf0674d3c836b65c0ed95.jpg)
About Tesla Diagnostix
Most Innovative Biomedical Diagnostic Application Development CEO – UK
<p>Tesla Diagnostix develops diagnostic tests that can quantify a variety of biomarkers, eliminating the need for health care professionals to send specimens to a laboratory. Its first flagship product is the world’s first saliva glucose diagnostic test (VitaLibra), obviating the need for finger pricking for diabetics. Transferring control of healthcare data to patients would be a game-changer, redefining patient experience as we now know it for a variety of healthcare conditions.</p>
Visit Website